
ViiV Healthcare is developing a self-injectable HIV drug similar to Cabenuva; HHS met with insurance companies to resolve COVID-19 vaccine coverage issues; the FDA has greenlit drugmaker Novo Nordisk to add reports of ileus, or intestinal blockage, to its Ozempic label.



![[COA seal]: credit: Community Oncology Alliance](https://cdn.sanity.io/images/0vv8moc6/ajmc/a53df4e70840b0125b6abde392aedb8661fd2cc1-750x750.webp?w=350&fit=crop&auto=format)


